Jeffrey Schlom focuses on Immunology, Antigen, Monoclonal antibody, Antibody and Molecular biology. His Immunology study combines topics in areas such as Cancer, Prostate cancer and Cancer research. Jeffrey Schlom has researched Antigen in several fields, including Carcinoembryonic antigen, T cell, Adjuvant, Vaccination and Tumor antigen.
His biological study spans a wide range of topics, including Radioimmunoassay, Transplantation and Pathology. He focuses mostly in the field of Antibody, narrowing it down to topics relating to In vivo and, in certain cases, Radiolabeled CC49. His research in Molecular biology intersects with topics in In vitro, Biodistribution, Recombinant DNA, Epitope and Antigen presentation.
Jeffrey Schlom mainly focuses on Immunology, Antigen, Monoclonal antibody, Cancer research and Immunotherapy. His Immunology research includes elements of Cancer and Cytotoxic T cell. Jeffrey Schlom interconnects Carcinoembryonic antigen, Radioimmunoassay, Tumor antigen and Virology in the investigation of issues within Antigen.
His Monoclonal antibody study incorporates themes from Molecular biology, In vivo and Pathology. His Molecular biology research includes themes of In vitro, Immunogen and Immunogenicity. His Cancer research research is multidisciplinary, incorporating perspectives in Cell culture, PD-L1, Cancer immunotherapy and Brachyury.
His primary areas of study are Cancer research, Immunotherapy, Immune system, Immunology and Cancer. Jeffrey Schlom has included themes like Cytotoxic T cell, PD-L1, CD8 and Brachyury in his Cancer research study. His Immune system research is multidisciplinary, relying on both Antibody-dependent cell-mediated cytotoxicity, Antigen, Peripheral blood mononuclear cell, Combination therapy and Antibody.
Jeffrey Schlom studies Epitope which is a part of Antigen. His In vitro research extends to the thematically linked field of Immunology. His work carried out in the field of Cancer brings together such families of science as Acquired immune system and Oncology.
His scientific interests lie mostly in Immunotherapy, Immunology, Cancer research, Immune system and Cancer. His Immunotherapy study introduces a deeper knowledge of Internal medicine. His studies deal with areas such as In vitro and Brachyury as well as Immunology.
His Immune system research incorporates themes from Peripheral blood mononuclear cell, Antibody, Antigen and Carcinoembryonic antigen. His specific area of interest is Antibody, where Jeffrey Schlom studies Monoclonal antibody. His Antigen research incorporates elements of Prostate-specific antigen and Vaccination, Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rapid Tumor Penetration of a Single-Chain Fv and Comparison with Other Immunoglobulin Forms
Takashi Yokota;Diane E. Milenic;Marc Whitlow;Jeffrey Schlom.
Cancer Research (1992)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
M. E. Christine Lutsiak;Roshanak T. Semnani;Roberto De Pascalis;Syed V. S. Kashmiri.
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff;Thomas J. Schuetz;Brent A. Blumenstein;L. Michael Glode.
Journal of Clinical Oncology (2010)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits;James W Hodge;Carla A Herberts;Tom A M Groothuis.
Journal of Experimental Medicine (2006)
Grafting of “Abbreviated” Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody
Roberto De Pascalis;Makoto Iwahashi;Midori Tamura;Eduardo A. Padlan.
Journal of Immunology (2002)
A spectrum of monoclonal antibodies reactive with human mammary tumor cells
D Colcher;P H Hand;M Nuti;J Schlom.
Proceedings of the National Academy of Sciences of the United States of America (1981)
Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine
Tsang Ky;Zaremba S;Nieroda Ca;Zhu Mz.
Journal of the National Cancer Institute (1995)
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.
Donald Kufe;Giorgio Inghirami;Miyako Abe;Daniel Hayes.
Distribution of Oncofetal Antigen Tumor-associated Glycoprotein-72 Defined by Monoclonal Antibody B72.3
Ann Thor;Noriaki Ohuchi;Cheryl A. Szpak;William W. Johnston.
Cancer Research (1986)
Analysis of a Human Tumor-associated Glycoprotein (TAG-72) Identified by Monoclonal Antibody B72.3
Virginia G. Johnson;Jeffrey Schlom;Andrew J. Paterson;Jeffrey Bennett.
Cancer Research (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: